n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride has been researched along with Brain Ischemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukunaga, K; Ikuno, T; Izumi, H; Shinoda, Y; Shioda, N; Yabuki, Y | 1 |
1 other study(ies) available for n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride and Brain Ischemia
| Article | Year |
|---|---|
Dehydroepiandrosterone administration improves memory deficits following transient brain ischemia through sigma-1 receptor stimulation.
Topics: Adenosine Triphosphate; Animals; Anisoles; Brain Ischemia; CA1 Region, Hippocampal; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Carotid Artery Diseases; Cell Death; Dehydroepiandrosterone; Disease Models, Animal; Dose-Response Relationship, Drug; Extracellular Signal-Regulated MAP Kinases; Male; Memory Disorders; Mice, Inbred C57BL; Narcotic Antagonists; Neurons; Neuroprotective Agents; Nootropic Agents; Propylamines; Proto-Oncogene Proteins c-akt; Receptors, sigma; Sigma-1 Receptor | 2015 |